Results 31 to 40 of about 2,377,546 (217)

Primers encoding for carbapenem-resistance.

open access: yes, 2023
Primers encoding for carbapenem-resistance.
Rael J. Too (14664679)   +5 more
core   +1 more source

Global Distribution of Extended Spectrum Cephalosporin and Carbapenem Resistance and Associated Resistance Markers in Escherichia coli of Swine Origin – A Systematic Review and Meta-Analysis [PDF]

open access: yes, 2022
Third generation cephalosporins and carbapenems are considered critically important antimicrobials in human medicine. Food animals such as swine can act as reservoirs of antimicrobial resistance (AMR) genes/bacteria resistant to these antimicrobial ...
Hayer, Shivdeep Singh   +9 more
core   +1 more source

Prevalence and 30-day all-cause mortality of carbapenem-and colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: Description of a decade-long trend

open access: yesInternational Journal of Infectious Diseases, 2019
Background: Bacteraemia due to carbapenem-resistant gram-negative bacteria is challenging. This study examined the burden of carbapenem and colistin resistance in Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii bacteraemia in ...
A. Balkhair   +7 more
doaj   +1 more source

Carbapenem resistance genes and biofilm-virulence uncoupling in <i>Acinetobacter baumannii</i>. [PDF]

open access: yesFront Antibiot
Introduction Acinetobacter baumannii , a World Health Organization (WHO) critical-priority pathogen, causes difficult-to-treat nosocomial infections.
Tripathi S   +7 more
europepmc   +2 more sources

Carbapenem Resistance Profile of Acinetobacter baumannii Complex Strains in the Intensive Care Unit of a University Hospital in Northern Cyprus: 3-Year Follow-up [PDF]

open access: yes, 2021
Objective:This study aimed to investigate the distribution of three-year carbapenem resistance of Acinetobacter baumannii complex (ABC) in hospital infections isolated from the intensive care unit in the last three years.Materials and Methods:The ...
Meryem Güvenir   +2 more
core   +1 more source

A review on bacterial resistance to carbapenems: epidemiology, detection and treatment options

open access: yesFuture Science OA, 2020
Carbapenems are a class of antimicrobial agents reserved for infections caused by multidrug-resistant microorganisms. The emergence of carbapenem resistance has become a serious public health threat.
Ann A Elshamy, Khaled M Aboshanab
doaj   +1 more source

Screening for Fosfomycin Resistance Genes in Carbapenem- Resistant Isolates of Enterobacterales from the Bloodstream of Liver Transplant Patients

open access: yesMediterranean Journal of Infection, Microbes and Antimicrobials, 2022
Introduction: Interest in fosfomycin, an old antibiotic, has been reignited because of the use of its intravenous formulation (fosfomycin sodium) in resistant infections.
Yakup GEZER   +4 more
doaj   +1 more source

Carbapenem stewardship with ertapenem and antimicrobial resistance-a scoping review

open access: yesRevista da Sociedade Brasileira de Medicina Tropical, 2020
Consumption of carbapenem has increased due to extended-spectrum beta-lactamase-producing bacteria spreading. Ertapenem has been suggested as a not carbapenem-resistance inducer.
Tiago Zequinão   +3 more
doaj   +1 more source

Excess mortality and long-term disability from healthcare-associated carbapenem-resistant Acinetobacter baumannii infections: A nationwide population-based matched cohort study.

open access: yesPLoS ONE, 2023
BackgroundCarbapenem resistance is perceived as a clinical challenge in the management of debilitated and immunocompromised patients who eventually will die from underlying diseases.
Chiu-Hsia Su   +3 more
doaj   +1 more source

Carbapenem resistance in extensively drug-resistant Salmonella enterica serovar Agona and AmpC β-lactamase-producing S. Infantis

open access: yesMicrobiology Spectrum, 2023
We report that carbapenem resistance developed in an extensively drug-resistant Salmonella enterica serovar Agona strain during antimicrobial therapy and in an AmpC β-lactamase-producing S. Infantis strain.
Ping-Chun Hsu   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy